Bonesupport Holding AB - Asset Resilience Ratio
Bonesupport Holding AB (BONEX) has an Asset Resilience Ratio of 37.71% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read BONEX current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Bonesupport Holding AB's Asset Resilience Ratio has changed over time. See Bonesupport Holding AB net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Bonesupport Holding AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Bonesupport Holding AB.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr379.02 Million | 37.71% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr379.02 Million | 37.71% |
Asset Resilience Insights
- Very High Liquidity: Bonesupport Holding AB maintains exceptional liquid asset reserves at 37.71% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Bonesupport Holding AB Industry Peers by Asset Resilience Ratio
Compare Bonesupport Holding AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Bonesupport Holding AB (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Bonesupport Holding AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 25.80% | Skr227.00 Million ≈ $24.43 Million |
Skr879.69 Million ≈ $94.67 Million |
+1.51pp |
| 2023-12-31 | 24.30% | Skr167.35 Million ≈ $18.01 Million |
Skr688.82 Million ≈ $74.13 Million |
-29.84pp |
| 2022-12-31 | 54.13% | Skr201.28 Million ≈ $21.66 Million |
Skr371.82 Million ≈ $40.01 Million |
-5.90pp |
| 2021-12-31 | 60.03% | Skr206.46 Million ≈ $22.22 Million |
Skr343.92 Million ≈ $37.01 Million |
-16.00pp |
| 2020-12-31 | 76.04% | Skr353.74 Million ≈ $38.07 Million |
Skr465.22 Million ≈ $50.06 Million |
+29.14pp |
| 2019-12-31 | 46.89% | Skr92.06 Million ≈ $9.91 Million |
Skr196.33 Million ≈ $21.13 Million |
-33.28pp |
| 2018-12-31 | 80.17% | Skr261.47 Million ≈ $28.14 Million |
Skr326.14 Million ≈ $35.10 Million |
-9.22pp |
| 2017-12-31 | 89.39% | Skr533.37 Million ≈ $57.40 Million |
Skr596.68 Million ≈ $64.21 Million |
+14.44pp |
| 2016-12-31 | 74.94% | Skr141.50 Million ≈ $15.23 Million |
Skr188.81 Million ≈ $20.32 Million |
-- |
About Bonesupport Holding AB
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin duri… Read more